RAISEing VEGF-D's importance as predictive biomarker for ramucirumab in metastatic colorectal cancer patients

Ann Oncol. 2018 Mar 1;29(3):527-529. doi: 10.1093/annonc/mdy028.

P Carmeliet^{1

2

3}, X Li¹, L Treps^{2

3}, L-C Conradi^{2

3}, S Loges^{4

5}

¹ State Key Laboratory of Ophthalmology (SKLO), Zhongshan Ophthalmic Center (ZOC), Sun Yat-Sen University, Guangzhou, P.R. China.
² Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology and Leuven Cancer Institute (LKI), Leuven, Belgium.
³ Laboratory of Angiogenesis and Vascular Metabolism, VIB Center for Cancer Biology, Leuven, Belgium.
⁴ Department of Oncology and Hematology with Sections BMT and Pneumology.
⁵ Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

No abstract available

Publication types